@ARTICLE{
author={Kolberg Hans-Christian,Colleoni Marco A,Demetriou Georgia Savva,Santi Patricia Xavier,Tesch Hans,Fujiwara Yasuhiro,Tomasevic Zorica I,Hanes Vladimir},
year={2020},
title={Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study},
journal={DRUG SAFETY},
volume={43},
number={3},
pages={233-242},
document_type={Article},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Colleoni Marco A,Sawa-Demetriou G,Santi Patricia Xavier,Tesch Hans,Fujiwara Yasuhiro,Tomasevic Zorica I,Hanes Vladimir},
year={2019},
title={Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Lilac Study},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={29},
number={},
pages={A55-A55},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Colleoni Marco A,Demetriou Georgia Savva,Santi Patricia Xavier,Tesch Hans,Fujiwara Yasuhiro,Tomasevic Zorica I,Hanes Vladimir},
year={2019},
title={Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={37},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Colleoni Marco A,Tomasevic Zoran M,Ponomarova O,McBride HJ,Tesch Hans,Hanes Vladimir},
year={2019},
title={Matching the critical function of the biosimilar ABP 980 and trastuzumab: Totality of evidence and scientific justification for extrapolation across trastuzumab indications},
journal={CANCER RESEARCH},
volume={79},
number={4},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Tomasevic Zoran M,Demetriou Georgia S,von Minckwitz Gunter,Fujiwara Yasuhiro,Ponomarova O,Tesch Hans,Santi Patricia Xavier,Hanes Vladimir},
year={2018},
title={Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications},
journal={EUROPEAN JOURNAL OF CANCER},
volume={92},
number={},
pages={S103-S104},
document_type={Meeting Abstract},
}